VPIM
SGMO

Vanguard Personalized Indexing Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.01K Buy
32,433
+4,390
+16% +$1.75K ﹤0.01% 2160
2025
Q4 		$11.8K Sell
28,043
-7,468
-21% -$3.96K ﹤0.01% 1959
2025
Q3 		$23.9K Buy
35,511
+11,776
+50% +$6.35K ﹤0.01% 1959
2025
Q2 		$12.8K Sell
23,735
-1,091
-4% -$648 ﹤0.01% 1923
2025
Q1 		$16.3K Buy
24,826
+2,724
+12% +$2.88K ﹤0.01% 1796
2024
Q4 		$22.5K Sell
22,102
-418
-2% -$764 ﹤0.01% 1760
2024
Q3 		$19.5K Sell
22,520
-951
-4% -$697 ﹤0.01% 1734
2024
Q2 		$8.41K Buy
23,471
+705
+3% +$381 ﹤0.01% 1687
2024
Q1 		$15.3K Buy
22,766
+9,023
+66% +$6.54K ﹤0.01% 1612
2023
Q4 		$7.47K Sell
13,743
-29,314
-68% -$13.5K ﹤0.01% 1557
2023
Q3 		$25.8K Buy
+43,057
New +$46.1K ﹤0.01% 1441

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Vanguard Personalized Indexing Management's SGMO Position: Q1 2026 in Review

Vanguard Personalized Indexing Management increased its SANGAMO THERAPEUTICS INC (SGMO) stake by 16% in Q1 2026, buying an estimated $1.75K and bringing the position to 32,433 shares worth $8.01K. The position accounts for ﹤0.01% of the portfolio, ranked #2160.

Vanguard Personalized Indexing Management first reported a position in SGMO in Q3 2023 and has held it in 11 quarters since. The position peaked at $25.8K in Q3 2023. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Vanguard Personalized Indexing Management held 32,433 shares of SANGAMO THERAPEUTICS INC worth $8.01K as of Q1 2026.
  • Vanguard Personalized Indexing Management bought 4,390 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $1.75K.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #2160 holding.
  • Vanguard Personalized Indexing Management first reported a position in SANGAMO THERAPEUTICS INC in Q3 2023 and has held it in 11 quarters since.
  • Vanguard Personalized Indexing Management's SANGAMO THERAPEUTICS INC position peaked at $25.8K in Q3 2023.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.